Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/7/2025

Antiepileptic Medications Safe for Patients with Transaminitis

  • The American Academy of Neurology recommends Levetiracetam as a first-line treatment option for patients with transaminitis due to its minimal hepatic metabolism and excellent safety profile 1, 2, 3
  • Lacosamide is a suitable alternative with minimal hepatic metabolism and availability in both oral and intravenous formulations 1, 2, 3
  • The American College of Clinical Pharmacology suggests that Gabapentin and Pregabalin can be used for partial seizures, as they do not undergo hepatic metabolism 3
  • Topiramate is effective for various seizure types and can be used safely in patients with liver dysfunction 3

Medications to Avoid

  • The National Institute of Neurological Disorders and Stroke advises against the use of Asam valproat (valproic acid) due to its association with hepatotoxicity 4
  • Phenytoin should be avoided because it undergoes extensive hepatic metabolism and is associated with hepatotoxicity 4
  • Carbamazepine should be avoided due to its extensive hepatic metabolism and potential to induce hepatotoxicity 4
  • Felbamate, Phenobarbital, and primidone should also be avoided due to their potential for hepatotoxicity and induction of hepatic enzymes 4

Treatment Algorithm

  • The first-line treatment option is Levetiracetam 500-1500 mg loading dose orally or intravenously 3
  • Lacosamide is a suitable alternative if Levetiracetam is not tolerated 1, 2, 3
  • Gabapentin or Pregabalin can be used for partial seizures, and Topiramate can be used for a broader spectrum of seizures 3
  • Lamotrigine can be considered with caution due to its hepatic metabolism, but it has a relatively good safety profile 1, 2, 3

Management of Epilepsy in Patients with Transaminitis

  • The American Academy of Neurology recommends levetiracetam as a first-line treatment option for patients with transaminitis, due to its minimal hepatic metabolism and good safety profile, with a loading dose of 500-1500 mg oral or intravenous 5

Monitoring and Precautions

  • Monitoring of liver enzymes is required for patients on levetiracetam, despite its considered safety, due to reports of transient transaminitis as a rare side effect in the treatment of status epilepticus 5